Long-term Effects and Anorectal Function in Patients with Anal Squamous Cell Carcinoma Following Intensity-Modulated Radiotherapy - Scorecard - MDSpire

Long-term Effects and Anorectal Function in Patients with Anal Squamous Cell Carcinoma Following Intensity-Modulated Radiotherapy

  • By

  • Tongzhen Xu

  • Jinming Shi

  • Huiying Ma

  • Jiacheng Shuai

  • Shulian Wang

  • Yongwen Song

  • Yueping Liu

  • Hui Fang

  • Ningning Lu

  • Shunan Qi

  • Bo Chen

  • Yirui Zhai

  • Wenwen Zhang

  • Hao Jing

  • Yexiong Li

  • Ning Li

  • Yuan Tang

  • Jing Jin

  • January 27, 2026

  • 0 min

Share

Clinical Scorecard: Long-term Effects and Anorectal Function in Patients with Anal Squamous Cell Carcinoma Following Intensity-Modulated Radiotherapy

At a Glance

CategoryDetail
Condition
Key MechanismsDefinitive chemoradiation with 5-fluorouracil and mitomycin-C improves quality of life through sphincter preservation and colostomy obviation.
Target Population
Care Setting

Key Highlights

  • IMRT optimizes dose delivery while minimizing exposure to organs at risk, particularly in the context of SCCA treatment.
  • High rates of acute adverse events (up to 74%) can lead to treatment interruptions, impacting disease control.
  • Anorectal function assessed using Wexner, Vaizey, and LARS scales, with specific scoring implications.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Monitor for acute and late adverse events using NCI-CTCAE, noting that grade 3 and 4 adverse event rates can reach 13% for late effects.

      Risks

        Patient & Prescribing Data

        Concurrent chemotherapy with MMC administered as an intravenous bolus of 12 mg/m² on days 1 and 29, combined with continuous-infusion 5-fluorouracil or oral capecitabine.

        Clinical Best Practices

        • Utilize IMRT for improved targeting and reduced toxicity, and ensure regular assessment of anorectal function post-treatment using validated scales.

        References

        Original Source(s)

        Long-term Effects and Anorectal Function in Patients with Anal Squamous Cell Carcinoma Following Intensity-Modulated Radiotherapy

        • by Tongzhen Xu, Jinming Shi, Huiying Ma, Jiacheng Shuai, Shulian Wang, Yongwen Song, Yueping Liu, Hui Fang, Ningning Lu, Shunan Qi, Bo Chen, Yirui Zhai, Wenwen Zhang, Hao Jing, Yexiong Li, Ning Li, Yuan Tang, Jing Jin

        • January 27, 2026

        Related Content

        The Loan Cap That Could Shrink the Doctor Pipeline

        New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

        Comprehensive Bioinformatics Examination of Variations Between Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma

        AI Model Differentiates BCC vs cSCC Subtypes

        External validation identifies calibration shift in COBRA cohort.